3 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 2 with minor changes only.
Primary endpoint(s) modified
ModernaTX, Inc.Phase 4 NCT07266558 Registry history of NCT07266558 on ClinicalTrials.gov (opens the registry)
Updated
Enrollment closed, study ongoing
ModernaTX, Inc.Phase 1 NCT07737717 Registry history of NCT07737717 on ClinicalTrials.gov (opens the registry)
Updated
Enrollment increased: 166 → 190 participants
ModernaTX, Inc.Phase 1/2 NCT07116616 Registry history of NCT07116616 on ClinicalTrials.gov (opens the registry)
Updated
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-13 | NCT07870330 A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in… | Phase 1 | Not Yet Recruiting |
| 2026-10-07 | NCT07863635 A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing… | Phase 4 | Not Yet Recruiting |
| Phase 1 | 9 | |
| Phase 1/2 | 8 | |
| Phase 2 | 5 | |
| Phase 3 | 2 | |
| Phase 4 | 3 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06585241 | A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing… | SARS-CoV-2 | Recruiting | 2026-03-27 |
| NCT07863635 | A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing… | SARS-CoV-2 | Not Yet Recruiting | 2026-10-07 |
| NCT07266558 | A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50… | SARS-CoV-2 | Active, Not Recruiting | 2026-09-28 |
| Phase 3 | ||||
| NCT07496450 | A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults | Influenza | Active, Not Recruiting | 2026-08-11 |
| NCT06592794 | A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of… | Acute Gastroenteritis | Active, Not Recruiting | 2026-05-13 |
| Phase 2 | ||||
| NCT06735248 | A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With… | Multiple Sclerosis | Recruiting | 2026-06-15 |
| NCT07808697 | A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in… | SARS-CoV-2 | Not Yet Recruiting | 2026-09-09 |
| NCT03897881 | An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157… | Melanoma | Active, Not Recruiting | 2026-09-08 |
| NCT05683457 | A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus… | Cytomegalovirus Infection | Active, Not Recruiting | 2026-08-10 |
| NCT07561294 | A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to… | Lyme Disease | Active, Not Recruiting | 2026-08-03 |
| Phase 1/2 | ||||
| NCT07116616 | A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma | Relapsed or Refractory Multiple Myeloma | Recruiting | 2026-09-23 |
| NCT05533697 | Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade… | Advanced Solid Tumors | Recruiting | 2026-07-14 |
| NCT05130437 | A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants… | Propionic Acidemia | Recruiting | 2026-03-23 |
| NCT04159103 | Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia | Propionic Acidemia | Recruiting | 2026-01-22 |
| NCT05295433 | An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in… | Methylmalonic Acidemia | Recruiting | 2025-12-23 |
| NCT05164094 | A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to… | Epstein-Barr Virus Infection | Active, Not Recruiting | 2026-05-06 |
| NCT05992935 | Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and… | Norovirus Acute Gastroenteritis | Active, Not Recruiting | 2026-04-03 |
| NCT05095727 | A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease… | Glycogen Storage Disease | Active, Not Recruiting | 2025-12-15 |
| Phase 1 | ||||
| NCT06880549 | A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer… | Advanced Solid Tumors | Recruiting | 2026-10-13 |
| NCT06655870 | A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously… | Healthy Participants | Recruiting | 2026-09-15 |
| NCT07764237 | A Study to Investigate Safety, Reactogenicity, and Immunogenicity of mRNA-1365 (Profile… | Respiratory Syncytial Virus (RSV) | Recruiting | 2026-08-19 |
| NCT07478952 | A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18… | Epstein-Barr Virus | Recruiting | 2026-03-24 |
| NCT07870330 | A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in… | Seasonal Influenza | Not Yet Recruiting | 2026-10-13 |
| NCT07737717 | A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of mRNA-1469… | Ebola-Bundibugyo Virus Disease (Ebola-BDBV) | Active, Not Recruiting | 2026-09-24 |
| NCT03313778 | Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in… | Solid Tumors | Active, Not Recruiting | 2026-09-03 |
Melanoma (2) · Heart Disease (1) · Multiple Myeloma (1) · Multiple Sclerosis (1)